In the States
VERMONT: State May Get Even Tougher on Pharma Payments to Doctors More
Doctors Got $2.9 Million From Drugmakers in 2008 More
MASSACHUSETTS: Hospital Group Adopts Rules To Govern Ties With Drug, Device Companies More
NEW YORK: Gov. Paterson Signs Budget Legislation
With Provisions to Reduce Rx Drug Costs More
CONNECTICUT: Governor Proposes Raised Enrollment Fee for Prescription Program More
TENNESSEE: TennCare Prescription Drug Use Declined After Cap Took Effect More
WASHINGTON: Court Bars Washington State From Cutting Pharmacy Medicaid Reimbursements
More
NEW JERSEY: Proposed Corzine Budget Includes Medicaid Drug Co-Payments More |
Outrage of the Week
Researcher Faked Data in Sleep Apnea Study More
|
Prices and Access to Healthcare
AARP Study Finds Price of Brand-Name Prescription Drugs Increasing While Price of Generic Drugs Decreasing More
Drugmakers Hike Prices to Boost Revenues More
Drug Makers, Hospitals Raise Prices More
A Way to Save Billions and Improve Healthcare More
Drug, Medical Device Companies Worry Comparative Effectiveness Research Will Limit Patient Options More
Report Says New York Prescription Drug Price Comparison Web Site Is Inconsistent More |
Patents and Generics
J&J Supports Biosimilars Bill Proposed
By Rep. Barton With Longer Protections More
Sebelius Gives Views on Generics and Imports More
Clarinex Patent Litigation Settlement Reached More
Generics Are Real and Really Impacting Household and Employer Economies More
Generic Drugs Can Be Good For Your Health And Your Wallet More
|
Advertising and Marketing
FDA Rules on Drug Ads Sow Confusion as Applied to Web More
Pharmaceutical Companies Concerned About FDA's Rules for Google Internet Search Ads More
Should FDA Show Us the Search Ad Data? More
Drugmakers Reduce Spending on Prescription Drug Advertising More
Industry Crops DTC Spending by 8% More
Pharmaceutical Sales Reps Often Find the Doctor Won't See Them Now More
J & J Eliminates 900 Sales Positions More
Hopkins bans gifts, drug samples More
Comments on "DTC Perspectives" Conference More
Former Merck Rep Runs Program to Detail Docs on Public Health More
|
Conflicts of Interest
Johns Hopkins, Partners HealthCare Announce New Conflict-of-Interest Policies More
Medical Researchers Face Conflicts of Interest More
Study Author in JAMA Disclosure Flap Has His Say More
|
Pharma Watch
Pharma Looks to Biotech for R&D Model More
Big Pharma's Global Generics Push Continues With Sanofi Deal More
Generics Drag on Glaxo; Gilead Profits Up 21% More
Biogen Posts 50% Growth in Profits More
Pharma Deals Way Up in First Quarter of 2009 More
Group Wants FTC to Examine Mergers, Potential Effects on Rx Drug Innovation More
Glaxo Buys Stiefel Labs for $2.9 Billion More
Deal-Happy Sanofi to Buy Cancer-Drug Developer More
Carl Icahn Aims to Sell Amylin to Lilly More
Roche & Genentech Combine Some R&D More
Pfizer Makes HIV Pact with Glaxo More
Big Leadership Changes at Genentech More
Abbott CEO: 'We're Not Necessarily Looking for Any Large M&A' More
Bristol, Biogen CEOs: We're Not Rushing to Be Acquired More
Drugmakers Lobby Hard for Healthcare Reform They'll Like More
Drug Makers Talk Up Comparative Effectiveness, Sort Of More
|
PBM Watch
Express Scripts to Acquire WellPoint's PBM Subsidiaries More
Express Scripts' Acquisition of WellPoint PBM
Could Lower Drug Prices for Employer Customers More
CVS Caremark's Smaller Competitors Seek Government Review More
|
Medicare
Medicare Spending on Outpatient Drugs
Spiked in Part D's First Year, AHRQ Says More
Shift from Injections to Pills Can Raise Costs of Treatment for Cancer Patients More
Use of Biologics in Part D Limited,
But Increasing, MedPAC Analyst Says More
Case Flash: Getting Compatible Drug Coverage for Your Medicare Health Plan More
Will Comparative Data Lead to Coverage Denied? More
|
Medicaid
Families USA and PhRMA to Lobby for Medicaid Expansion More
Covering the Uninsured in Medicaid More
|
Safety and Clinical Trials
New FDA Data Shows Adverse Event Reporting Increases Dramatically More
FDA Gets Permanent Injunction Against Neilgen, Advent Pharmaceuticals for Selling Defective Drugs More
Merck Suffers Blow Developing New Migraine Drug More
Abilify Versus Placebo: Are There Any Benefits? More
Study Finds Reflux Pills Are No Help for Asthma More
Comparative Effectiveness Among Key Health Reform Elements, Report Says More
Revised Clinical Trial Principles Reinforce PhRMA's Commitment To Transparency and Strengthen Authorship Standards More
Silicone Can Carry High Cost in Bid to Look Good More
General Practitioners Warning on Internet Drug Sales More |
Executive Branch Appointments
DHHS Nominee Kathleen Sebelius Approved by Senate Finance Committee More
Sebelius Tells Finance Committee All Options For Lowering Drug Costs Should Be Examined More
Obama Names Chief Technology, Performance Officers More
Obama Executive Order Establishes White House Office of Health Reform More
|
Electronic Records
Obama Announces Effort To Create New Electronic Health Record System for Veterans That Will Link DOD, VA Records More
Electronic Health Records Raise Doubt More
Are Electronic Health Records Worth the Risks? More
|
Editorials and Op-Eds
BNA Report on Regulation of Prescribing Data: Are States Getting It Wrong on Privacy? More
Op-Ed Defends Relationships Between Pharmaceutical Companies, Researchers More
It's Time to Fight the 'PharmaScolds' More
|
